Plantocol Launches Brand and Patent-Pending ATV Protocol for Lupus SLE Symptom Support

Miami, FL - January 27, 2025 - Plantocol, a forward-thinking supplement company, has officially launched its - brand, unveiling the innovative patent-pending ATV (Autotheravive) protocol aimed at supporting individuals managing the symptoms of Lupus SLE (Systemic Lupus Erythematosus). Pre-orders for this breakthrough supplement system are now available via the company's website, Plantocol.com.

Image: https://www.globalnewslines.com/uploads/2025/01/f905a855140af266eb75d50db58bb241.jpg

The ATV Protocol is a targeted, science-based approach that combines four carefully selected ingredients to address common concerns associated with Lupus SLE, such as fatigue, inflammation, and musculoskeletal discomfort. Designed to work synergistically, the protocol represents a fresh perspective on symptom management, using natural ingredients backed by emerging research.

The ATV Protocol includes:

*
Vitamin D3 + K2: Studies from the National Institutes of Health (NIH) indicate that Vitamin D3 can play a crucial role in immune system regulation, while Vitamin K2 supports bone health and helps mitigate inflammation-two prevalent concerns for those living with Lupus SLE.

*
Magnesium Complex: Research published in the Journal of Magnesium Research highlights magnesium's benefits in improving energy levels, reducing muscle pain, and alleviating stress, which are common challenges for Lupus patients.

*
Trans-Resveratrol 99% Standardized: Peer-reviewed studies from Oxidative Medicine and Cellular Longevity emphasize the antioxidant and anti-inflammatory properties of Trans-Resveratrol, offering relief from oxidative stress and chronic inflammation.

*
Solanum Dulcamara (Bittersweet Nightshade) Root Extract: Preliminary findings in the Journal of Ethnopharmacology suggest its immunomodulatory effects may help manage joint pain and skin-related symptoms associated with autoimmune conditions.

"Our goal with Plantocol is to empower those living with Lupus SLE by providing a solution rooted in research, innovation, and natural synergy," said Keven Pimentel, Founder of Plantocol. "This patent-pending protocol reflects our commitment to advancing natural health while addressing the unique needs of the autoimmune community."

What distinguishes Plantocol's ATV Protocol is its focus on synergy - ensuring that each component enhances the effectiveness of the others when taken as a complete system. By harnessing this approach, the company aims to provide Lupus SLE patients with a holistic option for symptom support.

The patent application for the ATV Protocol is currently filed with the U.S. Patent Office, underscoring Plantocol's dedication to delivering scientifically-driven, proprietary solutions to the health and wellness market.

Pre-orders are open now, with the first shipment scheduled for June 2025. For more details or to reserve your order, visitwww.plantocol.com [https://www.plantocol.com/].

Image: https://www.globalnewslines.com/uploads/2025/01/d589fb62909dc893b8a40fe5310a8515.jpg
Media Contact
Company Name: Plantocol
Contact Person: Keven Pimentel
Email: Send Email [http://www.universalpressrelease.com/?pr=plantocol-launches-brand-and-patentpending-atv-protocol-for-lupus-sle-symptom-support]
Country: United States
Website: https://www.plantocol.com/



This release was published on openPR.